Advertisement

Analgosedierung mit Opioiden

  • K. A. Lehmann
Conference paper
Part of the Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine book series (A+I, volume 200)

Zusammenfassung

Während die sog. kleinen (antipyretisch-antiphlogistischen) Analgetika wie Acetylsalicylsäure, Metamizol oder Paracetamol im Rahmen der operativen Intensivmedizin relativ unbedeutend sind, weil sie (für diese Art von Schmerzen) als zu wenig potent und hinsichtlich der Nebenwirkungen (Gerinnungshemmung, Schädigung der Magen-Darm-Schleimhaut) als zu gefährlich gelten, spielen Morphinderivate bei der medikamentösen Ruhigstellung traditionell eine entscheidende Rolle.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aitkenhead AR, Vater M, Achola K, Cooper CMS, Smith G (1984) Pharmacokinetics of single-dose i. v. morphine in normal volunteers and patients with en-stage renal failure. Br J Anaesth 56: 813–819PubMedCrossRefGoogle Scholar
  2. 2.
    Ausems ME, Stanski DR, Hug CC (1985) An evaluation of the accuracy of pharmacokinetic data for the computer assisted infusion of alfentanil. Br J Anaesth 57: 1217–1225PubMedCrossRefGoogle Scholar
  3. 3.
    Ball M, McQuay HJ, Moore RA, Allen MC, Fisher A, Sear J (1985) Renal failure and the use of morphine in intensive care. Lancet 1: 784–786PubMedCrossRefGoogle Scholar
  4. 4.
    Behne M, Asskali F, Steuer A, Förster H (1987) Midazolam-Dauerinfusion zur Sedierung von Beatmungspatienten. Anaesthesist 36: 228–232PubMedGoogle Scholar
  5. 5.
    Bingham RM, Hinds CJ (1987) Influence of bolus doses of phenoperidine on intracranial pressure and systemic arterial pressure in traumatic coma. Br J Anaesth 59: 592–595PubMedCrossRefGoogle Scholar
  6. 6.
    Bird TM, Edbrooke DL, Newby DM, Hebron BS (1984) Intravenous sedation for the intubated and spontaneously breathing patient in the intensive care unit. Acta Anaesthesiol Scand 28: 640–643PubMedCrossRefGoogle Scholar
  7. 7.
    Boulard G, Maurette P, Pouguet P et al (1983) Syndrome d’abstinence après arrêt de la sédation par fentanyl en neuro-réanimation. Ann Fr Anesth Réanim 2: 101–101Google Scholar
  8. 8.
    Bovill JG, Sebel PS, Blackburn CL, Heykants J (1982) The pharmacokinetics of alfentanil (R 39209): A new opioid analgesic. Anesthesiology 57: 439–443PubMedCrossRefGoogle Scholar
  9. 9.
    Bower S (1982) Plasma protein binding of fentanyl: The effect of hyperlipoproteinaemia and chronic renal failure. J Pharm Pharmacol 34: 102–106PubMedCrossRefGoogle Scholar
  10. 10.
    Brockmüller KD, Schwenzer N (1973) Ein neuer Weg zur Schmerzausschaltung bei extraoralen Abszeßeröffnungen. Dtsch Zahnärztl Z 28: 1004PubMedGoogle Scholar
  11. 11.
    Bromm B (Hrsg) (1984) Pain measurement in man. Neurophysiological correlates of pain. Elsevier, AmsterdamGoogle Scholar
  12. 12.
    Bullingham RES, McQuay HJ, Moore RA (1983) Clinical pharmacokinetics of narcotic agonist-antagonist drugs. Clin Pharmacokinet 8: 332–343PubMedCrossRefGoogle Scholar
  13. 13.
    Campbell D (1967) Pain relief in patients on ventilators. Br J Anaesth 39: 736–742PubMedCrossRefGoogle Scholar
  14. 14.
    Chauvin M, Bonnet F, Montembault C, Levron JC, Viars P (1986) The influence of hepatic plasma flow on alfentanil plasma concentration plateaus achieved with an infusion model in humans: Measurements of alfentanil hepatic extraction coefficient. Anesth Analg 65: 999–1003PubMedCrossRefGoogle Scholar
  15. 15.
    Chauvin M, Lebrault C, Levron JC, Duvaldestin P (1987) Pharmacokinetics of alfentanil in chronic renal failure. Anesth Analg 66: 53–56PubMedCrossRefGoogle Scholar
  16. 16.
    Chauvin M, Sandouk P, Scherrmann JM, Farinotti R, Strumza P, Duvaldestin P (1987) Morphine pharmacokinetics in renal failure. Anesthesiology 66: 327–331PubMedCrossRefGoogle Scholar
  17. 17.
    Chrubasik J, Falke K, Zindler M, Geller E, Niv D, Friedrich G, Schulte-Mönting J (1986) Indication for pulmonary metabolism of morphine? Schmerz Pain Douleur 7: 36–38Google Scholar
  18. 18.
    Chrubasik J, Geller E, Niv D, Zindler M (1987) Morphine inhalation versus intravenous infusion in pain treatment after abdominal surgery. Anesth Analg 66: S29CrossRefGoogle Scholar
  19. 19.
    Church JJ (1979) Continuous narcotic infusions for relief of postoperative pain. Br Med J 6: 977–978CrossRefGoogle Scholar
  20. 20.
    Cohen AT, Kelly DR (1987) Assessment of alfentanil by intravenous infusion as long-term sedation in intensive care. Anaesthesia 42: 545–548PubMedCrossRefGoogle Scholar
  21. 21.
    Corall IM, Moore RA, Strunin L (1980) Plasma concentrations of fentanyl in normal surgical patients and those with severe renal and hepatic disease. Br J Anaesth 52: 101 PGoogle Scholar
  22. 22.
    Dahlström B, Tamsen A, Paalzow L, Hartvig P (1982) Patient-controlled analgesic therapy, part IV: Pharmacokinetics and analgesic plasma concentrations of morphine. Clin Pharmacokinet 7: 266–279PubMedCrossRefGoogle Scholar
  23. 23.
    Dick W, Knoche E, Grundlach G, Klein I (1983) Klinisch experimentelle Untersuchungen zur postoperativen Infusionsanalgesie. Anaesthesist 32: 272–278PubMedGoogle Scholar
  24. 24.
    Doenicke A (1986) Langzeitsedierung des Intensivpatienten–Behandlung mit Opioiden. In: Schulte am Esch J (Hrsg) Langzeitsedierung des Intensivpatienten. Zuckschwerdt, München, S 14–26Google Scholar
  25. 25.
    Don HF, Dieppa RA, Taylor P (1975) Narcotic analgesics in anuric patients. Anesthesiology 42: 745–747PubMedCrossRefGoogle Scholar
  26. 26.
    Duthie DJR, McLaren AD, Nimmo WS (1986) Pharmacokinetics of fentanyl during constant rate i. v. infusion for the relief of pain after surgery. Br J Anaesth 58: 950–956PubMedCrossRefGoogle Scholar
  27. 27.
    Ferrier C, Marty J, Bouffard Y, Haberer P, Levron JC, Duvaldestin P (1985) Alfentanil pharmacokinetics in patients with cirrhosis. Anesthesiology 62: 480–484PubMedCrossRefGoogle Scholar
  28. 28.
    Fragen RJ, Booij LHDJ, Braak GJJ, Vree TB, Heykants J, Crul JF (1983) Pharmacokinetics of the infusion of alfentanil in man. Br J Anaesth 55: 1077–1081PubMedCrossRefGoogle Scholar
  29. 29.
    Haberer JP, Schoeffler P, Couderc E, Duvaldestin P (1982) Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth 54: 1267–1270PubMedCrossRefGoogle Scholar
  30. 30.
    Harmer M, Rosen M, Vickers MD (eds) (1985) Patient-controlled analgesia. Blackwell, OxfordGoogle Scholar
  31. 31.
    Hartenauer U (1982) Medikamentöse Sedierung während Langzeitbeatmung. In: Lawin P, Götz E, Huth H (Hrsg) Intravenöse Narkose und Langzeitsedierung. Thieme, Stuttgart New York, S 106–116Google Scholar
  32. 32.
    Hengstmann JH, Stoeckel H, Schüttler J (1978) Pharmacokinetics of fentanyl - evaluation of an infusion model. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 302: 252Google Scholar
  33. 33.
    Hengstmann JH, Stoeckel H, Schüttler J (1980) Infusion model for fentanyl based on pharmacokinetic analysis. Br J Anaesth 52: 1021–1025PubMedCrossRefGoogle Scholar
  34. 34.
    Hess R, Husmann K, Kettler D (1981) Blood levels of fentanyl during multiple injections and intravenous infusions of low and high doses: Approaching optimal conditions for “stress-free anaesthesia” Methods Find Exp Clin Pharmacol [Suppl] 3: 107S - 1145Google Scholar
  35. 35.
    Heuser D, Kottler B, Guggenberger H, Wagener B, Weigand H, Nieratschker I (1986) Aktuelle Aspekte zur Sedierungsproblematik bei Beatmungspatienten. Vortrag beim Internationalen Bremer Anästhesie Symposion, 17.-19. 4. 1986Google Scholar
  36. 36.
    Hoffmann P (1987) Kombination von Benzodiazepinen und Opioiden in der Intensivmedizin. Anaesthesist [Suppl] 36: 201Google Scholar
  37. 37.
    Hug CC (1984) Pharmacokinetics and dynamics of narcotic analgesics. In: Prys-Roberts C, Hug CC (eds) Pharmacokinetics of anaesthesia. Blackwell, Oxford, pp 187–234Google Scholar
  38. 38.
    Hynynen M, Takkunen O, Salemnperä M, Haataja H, Heinonen J (1986) Continuous infusion of fentanyl or alfentanil for coronary artery surgery. Plasma opiate concentrations, haemodynamics and postoperative course. Br J Anaesth 58: 1252–1259PubMedCrossRefGoogle Scholar
  39. 39.
    Kang YG, Uram M, Shiu GK, Bleyaert A, Martin J, Nemoto E, Starzl T (1984) Pharmacokinetics of fentanyl in end-stage liver disease. Anesthesiology 61: A380CrossRefGoogle Scholar
  40. 40.
    Keeri-Szanto M (1980) The kinetics of postoperative analgesia. Clin Pharmacol Ther 27: 263Google Scholar
  41. 41.
    Kobal G (1985) Pain-related electrical potentials of the human nasal mucosa elicited by chemical stimulation. Pain 22: 151–163PubMedCrossRefGoogle Scholar
  42. 42.
    Kobal G, Kamp HD (1985) Analgesimetry during anaesthesia using pain-related chemosomatosensory evoked potentials. Anaesthesist [Supp1]34: 47Google Scholar
  43. 43.
    Kochs E, Bause H (1986) Wirkungen von Langzeitsedierung auf Hormone des Hypophysen-NNR-Systems. In: Schulte am Esch J (Hrsg) Langzeitsedierung des Intensivpatienten. Zuckschwerdt, München, S 55–65Google Scholar
  44. 44.
    Kochs E, Schulte am Esch J (1984) Hormone des Hypophysen-Nebennierenrindensystems bei Patienten unter Langzeitsedierung mit Etomidate und Fentanyl. Anaesthesist 33: 402–407PubMedGoogle Scholar
  45. 45.
    Kurth M (1983) Anästhesie und Analgosedierung mit Ketamin bei Patenten einer Intensivstation. Anästh Intensivmed 24: 270–272Google Scholar
  46. 46.
    Lauven PM, Stoeckel H, Schüttler J (1982) Zur Pharmakokinetik der intravenösen Narkotika. In: Lawin P, Götz E, Huth H (Hrsg) Intravenöse Narkose und Langzeitsedierung. Thieme, Stuttgart New York, S 10–19Google Scholar
  47. 47.
    Lehmann KA (1984) On-Demand Analgesie: Neue Möglichkeiten zur Behandlung akuter Schmerzen. Arzneimittel Forsch 34: 1108–1114Google Scholar
  48. 48.
    Lehmann KA (1985) The pharmacokinetics of opioid analgesics (discussion). In: Harmer M, Rosen M, Vickers MD (eds) Patient-controlled analgesia. Blackwell, Oxford, pp 18–29Google Scholar
  49. 49.
    Lehmann KA (1986) Pharmakokinetik: Gibt es analgetische Blutkonzentrationen? In: Kettler D, Crozier T, Metzler H (Hrsg) Analgesie in der Anästhesie. Stellenwert der Morphinomimetika. Urban & Schwarzenberg, München, S 28–39Google Scholar
  50. 50.
    Lehmann KA, Gensior J, Daub D (1982) „Analgetische“ Fentanyl-Blutkonzentrationen unter Neuroleptanalgesie. Anaesthesist 31: 655–659Google Scholar
  51. 51.
    Mather LE (1983) Pharmacokinetic and pharmacodynamic factors influencing the choice, dose and route of administration of opiates for acute pain. In: Bullingham RES (ed) Opiate analgesia. Saunders, London (Clinics in Anaesthesiology, vol 1, no 1, pp 17–40 )Google Scholar
  52. 52.
    Mather LE (1983) Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8: 422–446PubMedCrossRefGoogle Scholar
  53. 53.
    McDonnell TE, Bartkowski RR, Bonilla FA, Henthorn TK, Williams JJ (1982) Nonuniformity of alfentanil pharmacokinetics in healthy adults. Anesthesiology 57: A236CrossRefGoogle Scholar
  54. 54.
    McQuay HJ, Moore A (1984) Be aware of renal function when prescribing morphine. Lancet 11: 384–385Google Scholar
  55. 55.
    McQuay HJ, Moore RA, Paterson GMC, Adams AP (1979) Plasma fentanyl concentrations and clinical observations during and after operation. Br J Anaesth 51: 543–550PubMedCrossRefGoogle Scholar
  56. 56.
    Merriman HM (1981) The techniques used to sedate ventilated patients. A survey of methods used in 34 ICUs in Great Britain. Intensive Care Med 7: 217–224PubMedCrossRefGoogle Scholar
  57. 57.
    Miller-Jones CMH, Williams JH (1980) Sedation for ventilation. A retrospective study of fifty patients. Anaesthesia 35: 1104–1107PubMedCrossRefGoogle Scholar
  58. 58.
    Moore RA, Sear W, Bullingham RES, McQuay HJ (1986) Morphine kinetics in renal failure. In: Foley KM, Inturrisi CE (eds) Advances in pain research and therapy, vol 8. Raven, New York, pp 65–72Google Scholar
  59. 59.
    Morgan RJM (1983) Rapid and safe withdrawal of intravenous papaveretum after prolonged continuous infusion. Anaesthesia 38: 492–494PubMedGoogle Scholar
  60. 60.
    Mostert JW, Evers JL, Hobika GH, Moore RH, Ambrus JL (1971) Cardiorespiratory effects of anaesthesia with morphine or fentanyl in chronic renal failure and cerebral toxicity after morphine. Br J Anaesth 43: 1053–1059PubMedCrossRefGoogle Scholar
  61. 61.
    Murrin KR, Rosen M (1985) Pain measurement. In: Smith G, Covino BG (eds) Acute pain. Butterworths, London, pp 104–132Google Scholar
  62. 62.
    Nassery W (1981) Plastische Chirurgie unter Analgosedierung. Z Plast Chir 5: 143–149PubMedGoogle Scholar
  63. 63.
    Nimmo WS, Todd JG (1985) Fentanyl by constant rate i. v. infusion for postoperative analgesia. Br J Anaesth 57: 250–254PubMedCrossRefGoogle Scholar
  64. 64.
    Norman J (1983) The i. v. administration of drugs. Br J Anaesth 55: 1049–1052PubMedCrossRefGoogle Scholar
  65. 65.
    O’Connor M, Escarpa A, Prys-Roberts C (1983) Ventilatory depression during and after infusion of alfentanil in man. Br J Anaesth 55: 217S - 222SPubMedGoogle Scholar
  66. 66.
    O’Connor M, Prys-Roberts C, Sear JW (1987) Alfentanil infusions: Relationship between pharmacokinetics and pharmacodynamics in man. Eur J Anaesth 4: 187–196Google Scholar
  67. 67.
    O’Dea J, Hopkinson R (1987) Alfentanil-midazolam infusion. Care Crit III 3: 20–21Google Scholar
  68. 68.
    Rawal N, Tandon B (1985) Epidural and intrathecal morphine in intensive care units. Intensive Care Med 11: 129–133PubMedCrossRefGoogle Scholar
  69. 69.
    Regnard CFB, Twycross RG (1984) Metabolism of narcotics. Br Med J 288: 860CrossRefGoogle Scholar
  70. 70.
    Reyes JG, Spain JA, Alvis JM, Ritchie RG (1984) Continuous infusion of fentanl during cardiac anesthesia: An automated system. Anesth Analg 63: 266Google Scholar
  71. 71.
    Rietbrock I (1982) Elimination und Wirkungsverlust intravenöser Narkotika. In: Lawin P, Götz E, Huth H (Hrsg) Intravenöse Narkose und Langzeitsedierung. Thieme, Stuttgart New York, S 29–41Google Scholar
  72. 72.
    Schulte am Esch J (1986) Ruhigstellung des Intensivpatienten–Sedierung oder Narkose? In: Schulte am Esch J (Hrsg) Langzeitsedierung des Intensivpatienten. Zuckschwerdt, München, S 1–6Google Scholar
  73. 73.
    Schüttler J, Stoeckel H, Schwilden H, Lauven PM (1983) Pharmakokinetisch begründete Infusionsmodelle für die Narkoseführung mit Alfentanil. Anaesthesist 32: 316–317Google Scholar
  74. 74.
    Schüttler J, Schwilden H, Stoeckel H (1986) Adaptive dosing strategies for alfentanil by computercontrolled infusion regimens. Eur J Anaesth 3: 67–68Google Scholar
  75. 75.
    Schwilden H, Stoeckel H, Schüttler J, Lauven PM (1986) Pharmacological models and their use in clinical anaesthesia. Eur J Anaesth 3: 175–208Google Scholar
  76. 76.
    Sear JW (1983) General kinetic and dynamic principles and their application to continuous infusion anaesthesia. Anaesthesia [Suppl] 38: 10–25Google Scholar
  77. 77.
    Sear J, Moore A, Hunniset A et al (1985) Morphine kinetics and kidney transplantation: Morphine removal is influenced by renal ischemia. Anesth Analg 64: 1065–1070PubMedCrossRefGoogle Scholar
  78. 78.
    Sear JW, Bower S, Potter D (1986) Disposition of alfentanil in patients with chronic renal failure. Br J Anaesth 58: 812 PGoogle Scholar
  79. 79.
    Shafer A, White PF, Schüttler J, Rosenthal MH (1983) Use of a fentanyl infusion in the intensive care unit: Tolerance to its anesthetic effects? Anesthesiology 59: 245–248PubMedGoogle Scholar
  80. 80.
    Shafer A, Sung ML, White PF (1985) Differences in pharmacokinetics contribute to postoperative respiratory depression after an alfentanil infusion. Anesthesiology 63: A283CrossRefGoogle Scholar
  81. 81.
    Shafer A, Sung ML, White PF (1986) Pharmacokinetics and pharmacodynamics of alfentanil infusions during general anesthesia. Anesth Analg 65: 1021–1028PubMedCrossRefGoogle Scholar
  82. 82.
    Shelly MP, Cory EP, Park GR (1986) Pharmacokinetics of morphine in two children before and after liver transplantation. Br J Anaesth 58: 1218–1223PubMedCrossRefGoogle Scholar
  83. 83.
    Sitar DS, Duke PC, Owen JA, Mitenko PA (1986) Kinetic disposition of morphine in young males after intravenous loading and maintenance infusions. Can Anaesth Soc J 33: 145–149PubMedCrossRefGoogle Scholar
  84. 84.
    Sprigge JM, Wynands JE, Whalley D, Bevan D, Nathan GE, Townsend GE, Patel Y (1982) Haemodynamic reponses and serum fentanyl levels during fentanyl. Can Anaesth Soc J 29: 495CrossRefGoogle Scholar
  85. 85.
    Sprigge JS, Wynands JE, Whalley DG et al (1982) Fentanyl infusion anesthesia for aortocoronary bypass surgery: Plasma levels and hemodynamic response. Anesth Analog 61: 972–978CrossRefGoogle Scholar
  86. 86.
    Sprigge JS, East DSR, Fox GS, Ogilvie RI, Otton PE, Bevan DR (1982) Meperidine infusion for postoperative analgesia in grossly obese patients. Can Anaesth Soc J 29: 142–147PubMedCrossRefGoogle Scholar
  87. 87.
    Stapleton JV, Austin KL, Mather LE (1979) A pharmacokinetic approach to postoperative pain: Continuous infusion of pethidine. Anaesth Intensive Care 7: 25–32PubMedGoogle Scholar
  88. 88.
    Stoeckel H, Oyama T (eds) (1980) Endocrinology in anaesthesia and surgery. Springer, Berlin Heidelberg New York (Anaesthesiologie und Intensivmedizin, Bd 132 )Google Scholar
  89. 89.
    Tamsen A, Hartvig P, Fagerlund C, Dahlström B (1982) Patient-controlled analgesic therapy, part II: Individual analgesic demand and analgesic plasma concentrations. Clin Pharmacokinet 7: 164–175PubMedCrossRefGoogle Scholar
  90. 90.
    Tamsen A, Bondesson U, Dahlström B, Hartvig P (1982) Patient-controlled analgesic therapy, part III: Pharmacokinetics and analgesic plasma concentrations of ketobemidone. Clin Pharmacokinet 7: 252–265PubMedCrossRefGoogle Scholar
  91. 91.
    Vogel W (1966) Über die Langzeitbehandlung mit Fentanyl und Dehydrobenzperidol. In: Gemperle M (Hrsg) Fortschritte der Neuroleptanalgesie. Springer, Berlin Heidelberg New York (Anaesthesiologie und Wiederbelebung, Bd 18, S 87–89 )Google Scholar
  92. 92.
    Voigt E (1975) Analgosedierung in der Hals-Nasen-Ohrenheilkunde bei operativen Eingriffen in Lokalanaästhesie. Prakt Anästh 10: 93–98Google Scholar
  93. 93.
    Vontin H, Heller W, Schorer R (1975) Analgosedierung und Ataranalgesie: Untersuchungen über „Rohypnol“ und Kombinationen mit Analgetika. In: Hügin W, Hossli G, Gemperle M (Hrsg) Bisherige Erfahrungen mit Rohypnol (Flunitrazepam) in der Anästhesiologie und Intensivtherapie. Editiones Roches, Basel, S 149–160Google Scholar
  94. 94.
    Wagner JG (1974) A safe method for rapidly achieving plasma concentration plateaus. Clin Pharmacol Ther 16: 691–700PubMedGoogle Scholar
  95. 95.
    Waldmann CS, Eason JR, Rambohul E, Hanson GC (1984) Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients. Anaesthesia 39: 768–771PubMedCrossRefGoogle Scholar
  96. 96.
    Wendt M (1982) Probleme bei der Entwöhnung nach Langzeitsedierung. In: Lawin P, Götz E, Huth H (Hrsg) Intravenöse Narkose und Langzeitsedierung. Thieme, Stuttgart New York, S 117–122Google Scholar
  97. 97.
    White PF, Sung ML (1985) Use of opiate infusions in anesthesia - determining optimal doses and serum concentrations. Anesth Analg 64: 299Google Scholar
  98. 98.
    White PF, Dworsky WA, Horai Y, Trevor AJ (1983) Comparison of continuous infusion fentanyl or ketamine versus thiopental–determining the mean effective serum concentrations for outpatient surgery. Anesthesiology 59: 564–569PubMedCrossRefGoogle Scholar
  99. 99.
    Yate PM, Thomas D, Sebel PS (1984) Alfentanil infusion for sedation and analgesia in intensive care. Lancet II: 396–397Google Scholar
  100. 100.
    Yale PM, Thomas D, Short SM, Sebel PS, Morton J (1986) Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ICU. Br J Anaesth 58: 1091–1099CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • K. A. Lehmann

There are no affiliations available

Personalised recommendations